[go: up one dir, main page]

HK40020378A - 用於治疗肺的癌症的多核苷酸toll样受体9激动剂 - Google Patents

用於治疗肺的癌症的多核苷酸toll样受体9激动剂 Download PDF

Info

Publication number
HK40020378A
HK40020378A HK42020010595.5A HK42020010595A HK40020378A HK 40020378 A HK40020378 A HK 40020378A HK 42020010595 A HK42020010595 A HK 42020010595A HK 40020378 A HK40020378 A HK 40020378A
Authority
HK
Hong Kong
Prior art keywords
pharmaceutical composition
polynucleotide
cancer
subject
lung
Prior art date
Application number
HK42020010595.5A
Other languages
English (en)
Inventor
Cristiana Guiducci
Robert L. Coffman
Original Assignee
Dynavax Technologies Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dynavax Technologies Corporation filed Critical Dynavax Technologies Corporation
Publication of HK40020378A publication Critical patent/HK40020378A/zh

Links

HK42020010595.5A 2015-05-29 2020-07-06 用於治疗肺的癌症的多核苷酸toll样受体9激动剂 HK40020378A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US62/168,449 2015-05-29
US62/168,470 2015-05-29
US62/169,321 2015-06-01
US62/169,309 2015-06-01
US62/276,767 2016-01-08

Publications (1)

Publication Number Publication Date
HK40020378A true HK40020378A (zh) 2020-10-23

Family

ID=

Similar Documents

Publication Publication Date Title
US10369168B2 (en) Administration of polynucleotide toll-like receptor 9 agonists for treating cancer
KR102039520B1 (ko) 암 치료에 이용하기 위한 gla 단일요법
WO2017143449A1 (en) Smc combination therapy for the treatment of cancer
EP2982679A1 (en) Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response
EP4286009A2 (en) Oncolytic vaccinia virus and checkpoint inhibitor combination therapy
JP7321489B2 (ja) がん免疫アジュバント
JP2016505265A (ja) 阻害性オリゴヌクレオチドおよび治療におけるその使用
KR20170100033A (ko) 분지형 및 선형 키메라 화합물, 폴리뉴클레오티드, 그것들의 용도 및 제조 방법
US20250333698A1 (en) SIRPa DEFICIENT MACROPHAGES FOR TREATING CANCER
US20210315991A1 (en) Combination including a cpg-c type oligonucleotide and a pd-1 antagonist for treating breast cancer
JP6536964B2 (ja) 免疫賦活活性を有する核酸多糖複合体の抗腫瘍薬としての応用
HK40020378A (zh) 用於治疗肺的癌症的多核苷酸toll样受体9激动剂
EP3607063A1 (en) Compositions and methods for differential induction of cell death and interferon expression
WO2024153142A1 (zh) CpG寡核苷酸及其应用
US20210403519A1 (en) Methods and compositions to induce or suppress immune responses through the use of membrane bound complement split products
HK40097178A (zh) 溶瘤痘苗病毒与免疫检查点抑制剂联合疗法
HK1255016A1 (zh) 通过组合疗法治疗实体或淋巴肿瘤的方法